Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-22 | ADPT | Cohen Chad M | CFO | M - OptEx | $7.27 | +10.0K | 31.6K | +46% | +$72.7K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Cohen Chad M | CFO | S - Sale+OE | $30.00 | -10.0K | 21.6K | -32% | -$300.0K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Cohen Chad M | CFO | M - OptEx | $0.00 | -10.0K | 80.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 10,000 | $7.27 | 31,604 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-22 | S | D | 10,000 | $30.00 | 21,604 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 10,000 | $0.00 | 80,000 | D | $7.27 · — to 2029-02-07 | 10,000 Common Stock | (F2) The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |